BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 2399883)

  • 21. Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study.
    Buxton AE; Marchlinski FE; Flores BT; Miller JM; Doherty JU; Josephson ME
    Circulation; 1987 Jun; 75(6):1178-85. PubMed ID: 3568327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Out-of-hospital cardiac arrest in patients with no overt heart disease: electrophysiologic observations and clinical outcome.
    Bhandari AK; Hong R; Au P; McKay CR; Rahimtoola SH
    Can J Cardiol; 1988 Mar; 4(2):80-4. PubMed ID: 3365601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of ventricular fibrillation predicts sudden death in patients treated with amiodarone because of ventricular tachyarrhythmias after a myocardial infarction.
    Rodríguez LM; Sternick EB; Smeets JL; Timmermans C; den Dulk K; Oreto G; Wellens HJ
    Heart; 1996 Jan; 75(1):23-8. PubMed ID: 8624866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation.
    Herre JM; Sauve MJ; Malone P; Griffin JC; Helmy I; Langberg JJ; Goldberg H; Scheinman MM
    J Am Coll Cardiol; 1989 Feb; 13(2):442-9. PubMed ID: 2913120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decline in inducibility of sustained ventricular tachycardia from two to twenty weeks after acute myocardial infarction.
    Bhandari AK; Au PK; Rose JS; Kotlewski A; Blue S; Rahimtoola SH
    Am J Cardiol; 1987 Feb; 59(4):284-90. PubMed ID: 3812277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol.
    Leite LR; Fenelon G; Simoes A; Silva GG; Friedman PA; de Paola AA
    J Cardiovasc Electrophysiol; 2003 Jun; 14(6):567-73. PubMed ID: 12875414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac arrest and sudden death in patients treated with amiodarone for sustained ventricular tachycardia or ventricular fibrillation: risk stratification based on clinical variables.
    DiCarlo LA; Morady F; Sauve MJ; Malone P; Davis JC; Evans-Bell T; Winston SA; Scheinman MM
    Am J Cardiol; 1985 Feb; 55(4):372-4. PubMed ID: 3969871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
    Veltri EP; Reid PR; Platia EV; Griffith LS
    Am J Cardiol; 1985 Feb; 55(4):375-9. PubMed ID: 3969872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiologic studies before and after myocardial revascularization in patients with life-threatening ventricular arrhythmias.
    Garan H; Ruskin JN; DiMarco JP; Derkac WM; Akins CW; Daggett WM; Austen WG; Buckley MJ
    Am J Cardiol; 1983 Feb; 51(3):519-24. PubMed ID: 6600577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amiodarone therapy: role of early and late electrophysiologic studies.
    Greenspon AJ; Volosin KJ; Greenberg RM; Jefferies L; Rotmensch HH
    J Am Coll Cardiol; 1988 Jan; 11(1):117-23. PubMed ID: 3335688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation.
    Olson PJ; Woelfel A; Simpson RJ; Foster JR
    Am J Cardiol; 1993 Apr; 71(10):823-6. PubMed ID: 8456761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of nonclinical ventricular tachycardia induced in amiodarone-treated patients.
    Belhassen B; Shapira I; Keren G; Laniado S
    Eur Heart J; 1985 Mar; 6(3):266-75. PubMed ID: 4029184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction.
    Piccini JP; Schulte PJ; Pieper KS; Mehta RH; White HD; Van de Werf F; Ardissino D; Califf RM; Granger CB; Ohman EM; Alexander JH
    Crit Care Med; 2011 Jan; 39(1):78-83. PubMed ID: 20959785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of early electrophysiologic testing in determining long-term outcome with amiodarone treatment in patients with sustained ventricular tachycardia.
    Shannon JA; Hammill SC; Gersh BJ
    Mayo Clin Proc; 1991 Nov; 66(11):1114-9. PubMed ID: 1943242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reproducibility of programmed electrical stimulation responses in patients with ventricular tachycardia or fibrillation associated with coronary artery disease.
    Volgman AS; Zheutlin TA; Mattioni TA; Parker MA; Kehoe RF
    Am J Cardiol; 1992 Sep; 70(7):758-63. PubMed ID: 1519526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induced sustained ventricular tachycardia in nonischemic dilated cardiomyopathy: dependence on clinical presentation and response to antiarrhythmic agents.
    Constantin L; Martins JB; Kienzle MG; Brownstein SL; McCue ML; Hopson RC
    Pacing Clin Electrophysiol; 1989 May; 12(5):776-83. PubMed ID: 2471163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy.
    Poll DS; Marchlinski FE; Buxton AE; Doherty JU; Waxman HL; Josephson ME
    Circulation; 1984 Sep; 70(3):451-6. PubMed ID: 6744550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (the CASCADE study).
    Am J Cardiol; 1991 Mar; 67(7):578-84. PubMed ID: 2000790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benefit and risks of long-term amiodarone therapy for sustained ventricular tachycardia/fibrillation: minimum of three-year follow-up in 145 patients.
    Myers M; Peter T; Weiss D; Nalos PC; Gang ES; Oseran DS; Mandel WJ
    Am Heart J; 1990 Jan; 119(1):8-14. PubMed ID: 2296879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.